Published Aug 10, 2008
justme1972
2,441 Posts
I have a list of drugs and drug categories that I am learning for my final that I have to take online this evening, and I am needing some help as my instructors notes are not clear...and the book is directly contradicting some of it...but I have a feeling that I am just getting confused.
I have to learn the drug CLASS Thrombolytic Agents/Fibrinolytics.
Our notes say: (and I'm only putting the portions that she wrote that is confusing)
You see why I'm confused?
Daytonite, BSN, RN
1 Article; 14,604 Posts
Heparin is almost always given immediately after a specific level of a thrombolytic has been achieved in order to maintain anticoagulation. Oral anticoagulation agents such as warfarin (Coumadin) which are long acting and take several days to build up in the blood are also started. When enough oral agent is present the IV heparin will be discontinued. The thrombolytic agent dissolves the clot; the anticoagulant prevents any more clots from forming. There are long acting and short acting thrombolytics now. Anticoagulants are contraindicated when there is known active bleeding which is what a hemorrhagic stroke is. Hemorrhage is not the same as a clot.
Thrombolytics are proteins also called thrombolytic enzymes or clotbusters. They stimulate the synthesis of fibrinolysin which is what breaks apart or dissolves a blood clot. The textbook I have, Pharmacology: An Introduction, 5th Edition, by Henry Hitner and Barbara, says: "At the end of the streptokinase or urokinase infusion, treatment usually continues with heparin infusion. Heparin is begun only after the thrombin time (PT, PTT) has decreased to less than 2 times the normal control (usually 3 to 4 hours after completion of urokinase infusion). . .Alteplase (tPA) is rapidly cleared from the blood within 5 to 10 minutes after [its] infusion is terminated. . .Thrombolytic enzymes are approved for use in the management of acute myocardial infarction, acute ischemic stroke, and pulmonary embolism. Streptokinase is also approved for lysis of deep vein thrombi." (page 299)
There are also different drugs used here and some act faster than others.
Thought you might have gotten caught up on the statement about the anticoagulants not being given for the 24 to 48 hours after the administration of a thrombolytic agent. That would be for streptokinase or urokinase because their effects last for 12 hours and sometimes as long as 24 hours according to one of my IV books. The reason the heparin isn't started for 24 to 48 hours with it is because the docs are waiting for the patient's PTT levels to come down to less than 2 times the normal control which is the accepted therapeutic goal for anticoagulation. If they start the heparin infusion before that they run the risk of the patient developing unwanted hemorrhaging. Keep in mind that the goal of thrombolysis is to bust up the clot, so let's do that safely first, then anticoagulate the guy--safely--next. tPA, on the other hand, is a short acting thrombolytic that has a super short half life and is out of the person's system in 10 minutes to 4 hours. To determine how soon the heparin infusion is started, PTTs are also done. Again, you don't want to start heparin too early and have the patient bleeding out on you until their PTT levels decrease to a safe level. When patients are getting these thrombolytic agents, PTT levels are being drawn almost minute-by-minute (well, not that much, but maybe hourly) and monitored very, very closely.
You do know the difference between a hemorrhagic stroke and an ischemic stroke, right?
Thought you might have gotten caught up on the statement about the anticoagulants not being given for the 24 to 48 hours after the administration of a thrombolytic agent. That would be for streptokinase or urokinase because their effects last for 12 hours and sometimes as long as 24 hours according to one of my IV books.
....and you would be correct!!!!
That was why I got confused.
THANK YOU! THANK YOU!
I halted at that statement too and kept going back to it. I wasn't sure if your confusion was because of the difference between the length of action of the tPA and the streptokinase or the hemorrhagic stroke. Did my explanation make sense? I re-wrote it several times.
Dianacabana
168 Posts
Daytonite, I'm always amazed by your knowledge! Terrific information.
Thanks!
actually, this one probably would make a lot more sense if you saw a patient in a clinical situation getting these drugs and lab tests so you could make the correlation with what was being said on paper. when i started thinking about what i saw as a nurse (we had to put 4 iv lines in these people before they started the tpa [#1 for the tpa, #2 for the heparin, #3 for blood draws and #4 for the nitroglycerin drip if they were having an mi] because of the danger of them hemorrhaging because we couldn't stick them once the tpa was started. the drugs are amazing through. when these people come in with an mi and get tpa you can see the blood clot melt away and their cardiac function improve right on the ekg monitor. it is so amazing! it actually saves their heart muscle from ischemic death.
which is another good thing to know :)
thanks again...i'll let you know how i do on my exam.
this is pharm iii (i have one more left)...i overloaded myself this semester with that class and my externship, so i haven't done too hot in this one. i have to get a 31 out of 50 to pass the class, and the scores so far have been running about 41/42..so i'm hopeful.
thank god it's only a one hour course...if it was 3 semester hour course, i would be flipping out.
we had a cardiac exam that i really bombed on, and that killed my average and put me behind.
i'm used to being ahead!!!
I did very well on my exam :)
I thought I was going to end up with a C but ended up with a B!!!!
Our Pharm is broke down into 4 semesters, at one semester hour each, so I wasn't going to flip out if I got a C (b/c so far, I haven't got one yet in school).
But it sure helps to know that I did better than that!
Thanks to everyone who helped and asked :)
sirI, MSN, APRN, NP
17 Articles; 45,819 Posts
congrats, hopefull2009
misswoosie
429 Posts
Sorry, just cam across this post and had to say that there is a BIG difference depending who you are thrombolysing. I have little experience with MI thrombolysis but a considerable amount with stroke.
1. 80% of strokes are infarcts (ie a blockage) whilst only 20% are haemaorrhages.
2. Clearly, you don't give thrombolytics, anticoagulants or antiplatelet agents to a haemorrhagic stroke (need CT to diagnose)
3. If a stroke patient is thrombolysed the agent will be rTpa -only one licensed.
4. Heparin is rarely given to any stroke patients because of the increased risk of haemorrhagic transformation in the brain infarct over the potential benefits of preventing further clots. This includes prophylactic doses.
5.Heparin is used for Cerebral Venous Thrombosis and may be used in patients that have carotid artery disection that causes stroke.